Organisation paid for research Program year 2021 Source: CMS Open Payments

Eye Center South

Neither a doctor nor a teaching hospital

Research payments

$57,773

42 payments

Through program year 2021, Eye Center South is reported as receiving $57,773 in research payments, across 42 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$7,810	5
2020	Research	$22,431	23
2019	Research	$27,532	14

Breakdown

Who paid Research payments · program years 2019–2021

Glaukos Corporation $54,420 23 payments
Allergan Inc. $1,617 4 payments
Boehringer Ingelheim Finland Ky $1,334 14 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $402 1 payment

Studies the money was for Research payments · program years 2019–2021

A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery $54,420 23 payments
Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension $1,617 4 payments
Anti-Sema3A for DMI in Treated PDR patients $1,334 14 payments
PoCP NPDR Study, 1 dose vs placebo, 12 wk $402 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.